移植并发症的临床试验
总计29036个结果
-
Swedish Orphan BiovitrumPRA Health Sciences; BioMérieux; Cytel Inc.终止
-
Hadassah Medical Organization完全的
-
National Institute of Nursing Research (NINR)Fred Hutchinson Cancer Center终止
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)终止
-
Shanghai General Hospital, Shanghai Jiao Tong University...未知
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)完全的
-
Colorado Blood Cancer Institute未知
-
Hospital Universitario Dr. Jose E. Gonzalez招聘中
-
Oncoimmune, Inc., a subsidiary of Merck & Co.,...National Cancer Institute (NCI); University of Michigan Rogel Cancer Center; Ohio State University 和其他合作者完全的Efprezimod Alfa (CD24Fc, MK-7110) 用于预防清髓性同种异体造血干细胞移植 (HSCT) 后急性移植物抗宿主病 (GVHD) 的 II 期试验 (MK-7110-002)白血病 | 造血干细胞移植 | 移植物抗宿主病美国
-
Children's Hospital Medical Center, Cincinnati终止
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Maryland Stem Cell Research Fund终止
-
Speedel Pharma Ltd.Quintiles, Inc.完全的
-
Washington University School of MedicineIncyte Corporation招聘中
-
Cliniques universitaires Saint-Luc- Université...招聘中
-
Ann & Robert H Lurie Children's Hospital of Chicago完全的
-
Jennifer E. SchwartzMillennium Pharmaceuticals, Inc.完全的
-
Peking University People's HospitalSun Yat-sen University; Third Military Medical University; Southern Medical University, China完全的
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey完全的
-
Astellas Pharma Korea, Inc.完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)未知移植物抗宿主病
-
Fred Hutchinson Cancer Research Center/University...National Cancer Institute (NCI)撤销
-
Roswell Park Cancer Institute完全的
-
Fundación Oftalmológica de Santander Clínica Carlos...Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud - IDCBIS尚未招聘移植物抗宿主病